Revolution Medicines, Inc. — Director's Dealing 2021

Jun 24, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Revolution Medicines, Inc. (RVMD)
CIK: 0001628171
Period of Report: 2021-06-22

Reporting Person: Borellini Flavia (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-22	Common Stock	A	7234	—	Acquired	7234	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-22	Stock Option (Right to Buy)	$32.93	A	25318	Acquired	2031-06-21	Common Stock (25318)	Direct

Footnotes

F1: Includes 7,234 Restricted Stock Units.

F2: The option becomes exercisable as it vests and the shares subject to the option vest with respect to 1/36 of the shares subject thereto on each monthly anniversary of June 22, 2021, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.